Helix BioMedix, Inc. (HXBM)
OTCMKTS
· Delayed Price · Currency is USD
7.18
-0.01 (-0.14%)
At close: Mar 5, 2025
Helix BioMedix Revenue
Helix BioMedix had revenue of $469.07K in the quarter ending September 30, 2012, with 18.84% growth. This brings the company's revenue in the last twelve months to $2.07M, up 14.56% year-over-year. In the year 2011, Helix BioMedix had annual revenue of $1.89M with 122.07% growth.
Revenue (ttm)
2.07M
Revenue Growth
+14.56%
P/S Ratio
0.78
Revenue / Employee
258.24K
Employees
8
Market Cap
1.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2011 | 1.89M | 1.04M | 122.07% |
Dec 31, 2010 | 851.68K | 460.42K | 117.67% |
Dec 31, 2009 | 391.27K | -171.61K | -30.49% |
Dec 31, 2008 | 562.88K | 98.94K | 21.33% |
Dec 31, 2007 | 463.94K | 393.00K | 553.99% |
Dec 31, 2006 | Pro | Pro | Pro |
Dec 31, 2005 | Pro | Pro | Pro |
Dec 31, 2004 | Pro | Pro | Pro |
Dec 31, 2003 | Pro | Pro | Pro |
Dec 31, 2002 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 20.65M |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |